Danske Bank A/S Edwards Lifesciences Corp Transaction History

Danske Bank A/S

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 19, 2025	BUY	$73.75 - $81.83 $23.2 Million - $25.7 Million	314,323 New	314,323 $24.4 Million
Q2 2025 Dec 18, 2025	BUY	$67.07 - $78.22 $1.84 Million - $2.14 Million	27,400 Added 9.89%	304,313 $23.8 Million
Q1 2025 Dec 18, 2025	SELL	$67.95 - $76.19 $2.54 Million - $2.85 Million	-37,410 Reduced 11.9%	276,913 $20.1 Million

1,460

468M

3.46M

4.07M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $53.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Danske Bank A/S, based on Form 13F filings with the SEC.

Stay updated on Danske Bank A/S with notifications on news.